Clinical trial
Triple Versus Dual Antiplatelet Therapy in Patients Undergoing Coronary Stent…
NCT00404716 · Shenyang Northern Hospital, Other · Completed
Key facts
| NCT number | NCT00404716 |
|---|---|
| Title | Triple Versus Dual Antiplatelet Therapy in Patients Undergoing Coronary Stent Implantation |
| Official title | Effects of Triple Versus Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome Undergoing Coronary Stent Implantation |
| Lead sponsor | Shenyang Northern Hospital, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Acute Coronary Syndrome |
| Intervention type | Drug |
| Interventions | Cilostazol |
| Start date | Dec 1, 2004 |
| Completion | Feb 1, 2007 |
| First posted | Nov 29, 2006 |
| Last update posted | Nov 29, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: